Skip to main content

Vireo Growth Inc.

corporate_fare Company Profile

Vireo Growth Inc.

VREOF·OTC·Life Sciences·CIK 0001771706

Vireo Growth Inc. is a cannabis company that cultivates, manufactures, wholesales, and retails cannabis products. The company aims to provide safe access, quality products, and value to customers while supporting local communities. Vireo Growth operates core businesses in six markets, cultivating and manufacturing cannabis products in environmentally friendly greenhouses and other facilities. These products are distributed through its network of Green Goods™ and other Vireo Growth branded retail dispensaries, as well as third-party dispensaries. As of March 17, 2026, Vireo Growth, through its subsidiaries, holds licenses and operates in six states: Maryland, Minnesota, Missouri, Nevada, New York, and Utah. The company retails cannabis products in 36 dispensaries located across Maryland (2), Minnesota (8), Missouri (11), Nevada (10), New York (4), and Utah (1). Vireo Growth also wholesales cannabis products through third-party companies in Maryland, Minnesota, Missouri, Nevada, New York, and Utah. The business was established in 2014 as Minnesota Medical Solutions, LLC, receiving its first license in December 2014. The company was incorporated on November 23, 2004, under the name "Initial Capital Inc." and changed its name to "Digifonica International Inc." on May 8, 2007.

Vireo Growth Inc. (OTC:VREOF) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 25 items for VREOF at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Shareholders to Vote on Major Reverse Stock Split and Substantial CEO Equity Awards
  • Vireo Growth Completes Eaze Acquisition, Restructures NY Operations, and Boosts CEO Equity Incentives
  • Vireo Growth Completes Major Acquisition of Schwazze Assets with $88.7M High-Interest Debt
  • Vireo Growth Reports 170% Revenue Surge, Positive Operating Cash Flow, and Major M&A Pipeline in 2025 Annual Report
  • Vireo Growth Reports 317% Q4 Revenue Surge, Strong EBITDA, and Active M&A

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$268.77M
Net Income
-$68.11M
Diluted EPS
-$0.09
Op. Cash Flow
$3.71M
Free Cash Flow
-$24.61M
Gross Profit
$127.1M
Operating Income
-$1.05M
Cash & Equivalents
$102.23M
Total Debt
$8.6M
Debt / Equity
0.03×
Net Margin
-25.3%
Shares Outstanding
734.74M sh
Source: 10-K · filed 2026-03-17 · accession 0001104659-26-029561
$12.85 +0.85% today
52-week range · as of 2026-08-18 $8.91 – $22.5
Market cap
$662.9M
Volume
114.8K (2.0× avg)
3-mo avg 58K
Live data · 2026-09-15 11:36 UTC · Pre-market

show_chartPrice Chart

Loading chart...

feed VREOF - Filings & News (Page 2)

VREOF
Apr 06, 2026, 4:20 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.4177
Real-time Price: $12.85 info
Change: Reverse Stock Split info
Market Cap: $662.903M info
VREOF
Apr 06, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.4177
Real-time Price: $12.85 info
Change: Reverse Stock Split info
Market Cap: $662.903M info
VREOF
Mar 25, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.420
Real-time Price: $12.85 info
Change: Reverse Stock Split info
Market Cap: $662.903M info
VREOF
Mar 17, 2026, 4:45 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.4205
Real-time Price: $12.85 info
Change: Reverse Stock Split info
Market Cap: $662.903M info
VREOF
Mar 17, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.4235
Real-time Price: $12.85 info
Change: Reverse Stock Split info
Market Cap: $662.903M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets